전혀 다른 병의 치료제로 허가 받은 약을 코로나19 치료에도 쓸 수 있도록 탈바꿈시키는 이른바 '약물 재창출' 시도다.
It is a so-called "drug re-creation" attempt to transform a drug licensed as a cure for a completely different disease so that it can also be used for treatment of COVID-19.